An interventional study of Low Level Laser Therapy and kinesio taping in Lymphedema and Breast Cancer Stage II, sponsored by Beni-Suef University. Completed at 2 sites in Egypt. Open to female participants aged 40 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Lymphedema with a site in Egypt — 3 open to participants now, 4 under way, none of them phase 3. Lymphedema · Egypt.
Among the 13 studies in Lymphedema with a site in Egypt, this one has the largest enrollment, is one of 3 that started in 2025, is one of 13 with no phase, and was the 12th registered.
529 studies on the registry are indexed under Lymphedema; 129 are open to participants now.
Browse Lymphedema studies →3 of the 13 studies in Lymphedema with a site in Egypt are open now. Recruiting first, the newest first:
South Valley University · Sites in Egypt
Ages 40–60 · Healthy volunteers
Assiut University · Sites in Egypt
Ages 20–65 · Women only
Cairo University · Sites in Egypt
Ages 45–55 · Healthy volunteers
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 84 Lymphedema studies recruiting now, 46 (55%) set no upper age limit and 21 (25%) stop at 75 or younger; 5 take children under 18; 12 take healthy volunteers.
This study: 40 Years to 55 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 3 started in 2025.
This study's enrollment of 90 is above the median of 52 across 369 interventional studies indexed under Lymphedema.
Median enrollment 60 across the 13 interventional studies. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 5 most frequent:
Beni-Suef University is the lead sponsor of 350 studies on the registry; 124 are open to participants now.
Beni-Suef University has 1 study filed under Lymphedema — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Lymphedema with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
find out the difference in the effect of kinesio taping and low level laser therapy on 90 patients with post mastectomy lymphedema as regards the following outcomes:
1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.
90 females with BCRL will be recruited in this study for 4 weeks , their age ranged from 40 to 55 years old with stege 1,2 lymphedema and randomly divided into 3 equal groups: 2) study group (A) include 30 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices 3) study group (B) include 30 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices 4) study group (C) include 30 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices regards the following outcomes:
1.girth measurement between the upper limbs 2.) SPADI 3) hand grip strength 4)the quality of life by cancer specific questionnaire.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
persistence of lymphedema following mastectomy or breast conservative surgery for at least 3 months
Exclusion Criteria:
Any disease lead to swelling
study group (A) include 30 females with unilateral BCRL will receive kinesio taping plus manual lymphatic drainage , exercise and advices
Other: kinesio taping
study group (B) include 30 females with unilateral BCRL will receive low level laser therapy plus manual lymphatic drainage , exercise and advices
Device: Low Level Laser Therapy
study group (C) include 30 females with unilateral BCRL will receive kinesio taping plus low level laser therapy and manual lymphatic drainage , exercise and advices
Device: Low Level Laser Therapy · Other: kinesio taping
The device has the following treatment parametes : * Maximum average power \> 500 milli watts * Wave length combined (904-808) nm * Maximum repition rate (1-2000) Hz * Energy density : 4:6 J per cm per session
* the material used is 100%acrylic,latex free and heat activated with 10-15% stretch. * It is made of 100% cotton to allow quickening of the drying process. * Ability to stretch to 120-140% of its original length * Recoil back to the anchor that is applied without stretch * Heat-activated adhesive * Hypoallergenic dyes that make the tape safe for most users * Latex-free * Drying time after being wet is about 5-10 minutes * Can be worn for several days
girth measurment
Measurement of arm circumference is the most commonly used technique for identifying lymphedema and is reliable for both surgical and nonsurgical upper limbs It is measured using a tape with the patient in prone lying position, with elbows straight and arms relaxed at the sides. It was measured starting with 3 cm on the ulnar styloid process and proceeding with 45 cm proximal, and additionally at the metacarpal bones and mid-hand. The tape measure was put around the limb to prevent it from slacking and to ensure that there was no space in the tissue. The total circumference of the sound limb was ascertained similarly. The difference between the 2 measurements was identified using "circumference difference."
Time frame: 4 weeks
shoulder pain and disability index
was used to assess shoulder pain and disability. It incorporates 13 items assessing 2 domains: 5 items assess pain and 8 items evaluate disability.
Time frame: 4 weeks
quality of life questionnaire
was assessed by cancer-specific questionnaire (EORTC QLQ-C30). It is composed of 30 questions, including functional scores (physical, social, emotional, and cognitive aspects). The functional scores ranged between 0 and 100, and higher scores indicated better condition. This questionnaire also included symptoms score (pain, dyspnea, fatigue, insomnia, nausea, loss of appetite, and financial problems). The symptom scores ranged from 100 to 0, and lower scores indicated better condition
Time frame: 4 weeks
handgrip strength
evaluated using a dynamometer ,The grip strength was measured with the patient in a standing position with adducted shoulder, elbow flexed at 90°, and forearm in mid position. The patient was instructed to do 3 trials with 15 seconds rest in between each, and the highest reading was reported
Time frame: 4 week
Ran from Feb 2025 to primary completion in Sep 2025, 7 months.
Of 175 non-industry interventional studies with no phase under Lymphedema, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 68. This study's 7 months is below that.
Counting every sponsor, half of 197 studies reached it within 25 months; a quarter within 11 and three quarters within 64.
Primary completion moved once since we started tracking on Sep 25, 2026: Jun 2025 → Sep 2025, on Nov 6, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.